Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Changing treatment

HIV: A therapeutic advance for resource-limited settings

Editor's pick
Eurekalert Inf Dis
31 May 2017
Pharmaceutical industry

Gilead and GSK go head-to-head with similar HIV drug data

Editor's pick
Reuters
31 May 2017
New & experimental HIV treatments

Gilead’s Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for the Treatment of HIV-1 Meets Primary Endpoint in Four Phase 3 Studies

Editor's pick
Gilead press release
30 May 2017
Adherence

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

News
30 May 2017
Contraception

Taking Birth Control With HIV Treatment or PrEP Is Largely OK

Editor's pick
Poz
30 May 2017
HIV treatment

The Truth About HIV

Editor's pick
BBC iPlayer (UK only, available until 24 June)
26 May 2017
Money

Life insurance policyholders with HIV urged to review life cover term

Editor's pick
Professional Adviser
24 May 2017
Generic medicines

Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs

Editor's pick
HIV i-Base
23 May 2017
New & experimental HIV treatments

Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS® (raltegravir) 600 mg in the European Union

Editor's pick
Merck press release
22 May 2017
Pharmaceutical industry

CHMP recommends for approval generic version of Atripla

Editor's pick
EATG
22 May 2017
The search for an HIV prevention vaccine

Stock market models accurately predict changes in HIV over time

Editor's pick
Healio
18 May 2017
Harm reduction

Combining drug addiction treatment and perinatal HIV prevention leads to good outcomes in Kenya

News
18 May 2017
History of HIV & AIDS

The HIV story is not over - the spectre of anti-science threatens our advances

Editor's pick
The Guardian
17 May 2017
Treatment outcomes & life expectancy

Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

News
15 May 2017
Starting treatment

Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes

News
12 May 2017
Pharmaceutical industry

Gilead's last chronic HIV drug — and what it plans to do now

Editor's pick
San Francisco Business Times
11 May 2017
Treatment outcomes & life expectancy

HIV life expectancy 'near normal' thanks to new drugs

Editor's pick
BBC Health
11 May 2017
Ageing & HIV

New Study Reveals why people with HIV are more likely to develop Emphysema

Editor's pick
Weill Cornell Medicine
10 May 2017
Neurological & cognitive problems

Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study

News
10 May 2017
Undetectable viral load & treatment as prevention

Gay New Zealand welcomes removal of HIV meds restriction

Editor's pick
Gay New Zealand
8 May 2017
Experiences of stigma

Fear of stigma is prompting young South Africans to seek early HIV treatment

News
4 May 2017
Starting treatment

Early ART highly acceptable and achieves excellent rates of viral suppression among young South African women

News
27 April 2017
Hepatitis B

EASL releases updated hepatitis B guidelines at International Liver Congress

News
26 April 2017
Access to healthcare

A quarter of people with second-line ART treatment failure in Kenya have exhausted current treatment options

News
25 April 2017